Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan
一项开放标签、随机、对照、交叉试验,旨在评估达格列净对接受托伐普坦治疗的ADPKD患者的影响
期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2025.01.023
Uchiyama, Kiyotaka; Kamano, Daisuke; Nagasaka, Tomoki; Hama, Eriko Yoshida; Shirai, Ryoichi; Sumura, Rena; Kusahana, Ei; Yanai, Akane; Nakayama, Takashin; Kimura, Takahide; Takahashi, Rina; Kasai, Takahiro; Tajima, Takaya; Hosoya, Koji; Azegami, Tatsuhiko; Yamaguchi, Shintaro; Yoshino, Jun; Ito, Jun; Hayashi, Matsuhiko; Kanda, Takeshi; Ishibashi, Yoshitaka; Washida, Naoki; Itoh, Hiroshi; Hayashi, Kaori